Water Ways Technologies Inc. (TSXV:WWT) (“Water Ways” or the “Company”) reports today its financial and business results and is pleased to provide highlights and comments on the results for the three months ended June 30, 2019. The Company’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

Ohad Haber, President, CEO and Chairman of the Board of Water Ways, commented: “The Company continues to witness development and expansion upon our listing on the TSX-V in the last quarter. We continue to increase our global footprint in the cannabis industry with the launch of CANNAWAYS with the intention of position Water Ways as a key technology provider to cannabis cultivators around the world.” Mr. Haber continued: “Completion of the Heartnut Grove acquisition provides us the platform to build a presence in the North American farming community and irrigation market. Simultaneously, we are entering new markets in Central Asia and South America and strengthening our existing markets such as Ethiopia with various new project delivered and to be delivered in the following months.” Mr. Haber continued: “While our revenue was slightly lower, compared to the same period in 2018, our project pipeline and new commercial accounts continue to expand, and we expect to recognize the revenue from the projects sourced in the first half of 2019 in subsequent quarters. We have never in the past had the level of activity we are witnessing and caution that as a cyclical agri-based business, it will take time for revenue from current activity to be recognized. We look forward to providing more exciting updates as the Company continues to expand its global footprint.”


Financial Highlights for the second quarter ended June 30, 20191

The following are financial highlights of Water Ways’ operating results for the three months ended June 30, 2019, compared to the three months ended June 30, 2018 and the first quarter ended March 31, 2019:

  • Revenue was C$4.17 million for the three months ended June 30, 2019 as compared to C$6.04 million for the three months ended June 30, 2018 and compared to C$1.98 million for the three months ended March 31, 2019.
    • The recognized revenues from service projects amounted to C$2.19 million for the three months ended June 30, 2019 as compared to C$4.11 million for the three months ended June 30, 2018 and compared to C$0.31 million for the three months ended March 31, 2019. The decrease compared to the same quarter in 2018 was mainly due to the shift in revenue recognized for the projects being completed the first half of 2019 to the second half of 2019. In addition, the Company is currently in the process of finalizing a substantial number of irrigation projects in China, Colombia, Israel and other countries, which are expected to be signed up in the second half of 2019, at which point the Company will begin recognizing the revenue once they are formally onboarded by the Company and are in the process of being completed. The Company estimates that the total value of pipeline of these projects irrigation projects will exceed C$5.3 million, of which two projects are in the final stages of signing (representing the value of approximately C$2.0 million) and the balance expected to be derived from projects in China that the Company has been in developing and onboarding since the end of 2018.
    • The revenues from sales of products amounted to C$1.98 million for the three months ended June 30, 2019, up approximately 18.4% from C$1.65 million for the three months ended March 31, 2019, and in-line with the C$1.92 million for the three months ended June 30, 2018. The Company’s major focus in 2019 has been preparation and business development efforts to do a sales push in South America, which has resulted in new relationships with the distributors that the Company expects to result in additional re-order business in 2019 and beyond. The increase in revenue in the second quarter of 2019 from the first quarter of 2019 was mainly as a result of these efforts and specifically as a result of increase in sales in Peru, as well as a large order received from one of the leading flower growers in South America.
  • Overall gross profit for the three months ended June 30, 2019 was C$607 thousand, which represents a gross margin of approximately 14.6%), compared to C$966 thousand for the three months ended June 30, 2018 (which represents a gross margin of 16%) and up from C$246 thousand for the three months ended March 31, 2019 (which represents a gross margin of approximately 12.4%). The decrease in gross profit from the previous year was primarily associated with the decrease in revenues from service projects over the period in 2018, due to recognition of certain projects being pushed into the second half of 2019. The decrease in the overall gross margin was primarily due to a decrease in the gross margin from the project services division, associated with higher costs entering new markets and mainly being attributed to the Company’s recent projects in Uzbekistan, which was the Company’s first project in Central Asia. Furthermore, the Company incurred commission expenses to its Chinese agent for the projects in China and the Company’s plans to establishing a new subsidiary in China in the next six months, in the effort to secure new business and increase sales growth in that region next year.
  • Operating expenses were C$670 thousand for the three months ended June 30, 2019 as compared to C$416 thousand for the three months ended June 30, 2018 and compared to C$330 thousand for the three months ended March 31, 2019. The increase in selling, general and administrative expenses in Q2 2019 was due to an increase in wages in first half of 2019, as the Company hired additional staff to support accelerating sales efforts worldwide and the entry into the cannabis irrigation business. The Company had also incurred additional expenses in connection with the financings and its “going public” process.
  • Total comprehensive income for the Company was C$75 thousand for the three months ended June 30, 2019 compared to total comprehensive income of C$458 thousand for the three months ended June 30, 2018 and compared to a total comprehensive loss of C$2,037 thousand in the first quarter of 2019. The Company believes that a lot of one time and new market entry costs have been incurred in the first half of 2019 and as the Company realizes the fruits of growth efforts that it has undertaken in the last 18 months and continues to scale its business in various units across the globe the financial performance metrics will become better reflect its profitability.
  • The Company had cash and cash equivalents of C$812 thousand as of June 30, 2019, as compared to C$317 thousand as of December 31, 2018.

Water Ways Technologies Financial Results Summary

The following tables set forth consolidated statements of financial information of Irri-Al-Tal Ltd. (“Irri-Al-Tal”) and Heartnut Grove WWT Inc. (“Heartnut”), wholly owned subsidiaries of the Company, since the reverse-takeover transaction between Irri-Al-Tal and the Company has occurred during the first quarter ended March 31, 2019.

Financial Highlights for the second quarter ended June 30, 2019 in YoY comparison to the second quarter ended June 30, 2018

water ways

Financial Highlights for the second quarter ended June 30, 2019 in QoQ comparison to the first quarter ended March 31, 2019

water ways

Business Highlights for the first quarter ended June 30, 2019

  • Cannabis Sectors Expansion

    Launch of CANNAWAYS
    In July 2019, the Company announced the launch of CANNAWAYS, an Internet of Things controlled irrigation and fertilization system for cannabis cultivators and growers, which is one of the first systems in the world that is designed specifically for cannabis growers and cultivators. The CANNAWAYS system was developed in Israel and had been already successfully tested at one cannabis cultivation site.

    The CANNAWAYS system will be sold and marketed first in Canada via the Company’s recently established Canadian subsidiary, Heartnut Grove WWT Inc. (see details below). The Company also intends to showcase the CANNAWAYS technology in the coming months at several cannabis shows internationally.

    Canada
    Following the successful implementation of a Cannabis project in Israel and one in Colombia, the Company has put a substantial amount of effort to penetrate the Canadian cannabis and hemp cultivation markets. Through its recent established subsidiary Heartnut Grove WWT Inc., the Company intends to penetrate the market by establishing ongoing distribution relationship with buyers of irrigation and cultivation equipment throughout the country.

    Europe and Latin America
    The Company is currently in negotiations to deliver turnkey irrigation solutions to cannabis and hemp cultivators in several European and Latin American countries and in Israel. The Company has entered an understanding with a veteran of the cannabis growing business and a former CEO of one of the first licensed producers in South America to single-source commercial cannabis and CBD Hemp cultivation solutions including dehumidification, lighting technologies, irrigation, fertigation and benching.

    Israel – Medical Cannabis
    The Company gained experience through its delivery of an irrigation, fertigation and Internet of Things control system to an Israeli subsidiary of Cronos Group (TSX: CRON), which is a greenhouse cultivation project located at Kibbutz Gan Shmuel, approximately 50km north of Tel Aviv. Hence, the Company is currently in the process of submitting bids for similar projects to a number of future licensed producers in the Israeli market. The Company expects to receive at least one additional project in Israel by the end of 2019.

  • Canadian Acquisition

    In June 2019, the Company closed the acquisition of certain assets of Heartnut Grove Inc. (“Heartnut”), a Canadian distributor of irrigation and agriculture components, established in 2004 and based in Mount Brydges, Ontario.

    Heartnut reported its year ended October 31, 2018 with sales of approximately C$3.74 million and associated costs of approximately $C3.07 million2, which include the cost of goods sold and operating costs.

    Water Ways intends to leverage Heartnut’s business relationships with the Canadian farming community to market and sell irrigation projects and components to the growing needs of Canadian cannabis licensed producers.

    Water Ways established a wholly owned Canadian subsidiary named Heartnut Grove WWT Inc. that acquired certain of Heartnut’s assets including its customer base, inventory, certain equipment and goodwill for total consideration of C$500 thousand.

    The Heartnut acquisition provides Water Ways exposure to the Canadian irrigation market by utilizing the established network and relationships that Heartnut’s management has built over the years and provide a point of entry into Canadian irrigation and cannabis irrigation market. While the Company has done business on four continents, this acquisition provides it the first permanent base of operations in North America.

  • Business Development

    Central Asia – Uzbekistan
    In July 2019, the Company completed its first irrigation project in Uzbekistan, which valued approximately C$480 thousand and was recognized in Q2 2019. The project irrigates via drip irrigation technology servicing a field of 160 hectares of cotton and includes a 20 km3 reservoir for sedimentation. The irrigation solution has been fully delivered to the client after a completion of the quality assurance inspection, and the operation of the system will start in Q3 2019 with agronomic and technical assistance from the Company. Water Ways believes that drip irrigation for cotton will be part of the Uzbekistan government’s national plan for water and soil conservation.

    East Africa – Ethiopia
    In July 2019, the Company signed two new irrigation projects in Ethiopia. The first project consists of the installation of advanced irrigation technology assembled at a 3,000-hectare sugar cane field and the supply of various components. The value of this project is approximately C$600 thousand and the Company expects it to be delivered and installed in the next several months. The second project consists of the upgrade of an existing 25-hectare herb greenhouse, valued approximately C$200 thousand. Both projects are guaranteed by letter of credits and the payments to the Company are expected in Q4 2019.

    South America
    In August 2019, Water Ways received a purchase order, from one of the South America’s leading flower growers, to deliver over 30 high tech water treatment solutions. The purchase order is valued at approximately C$1.5 million with the first systems to be delivered in Q4 2019 and the balance over a course of a few following months. The system would be tested by the client for over a year in field tests and once fully accepted, the Company will receive the full order for over 30 systems.

  • Appointment of Market Maker: In May 2019, the Company engaged the services of Lakeshore Securities Inc., a member of the Investment Industry Regulatory Organization of Canada (“IIROC”) and the Canadian Investor Protection Fund (“CIPF”), to provide services as a market maker for an initial term of three months.
  • Change of Auditors: In June 2019, the Company announced that it had appointed BDO – Ziv Haft Consulting and Management Ltd., the pre Securities Exchange auditor of Irri-Al-Tal Ltd., as the Company’s new auditor, replacing UHY McGovern Hurley LLP., Sagittarius Capital Corp.’s  pre Securities Exchange auditor.

Additionally, the Company wishes to provide notification of a correction to its press release dated June 21st, 2019 (the “June PR”). The June PR inadvertently stated that the Company granted a total of 3,723,527 stock options when in fact the Company granted a total of 3,973,527 stock options (“Participant Options”) to directors, employees and consultants pursuant to the terms of the Company’s stock option plan. Of this amount 1,000,000 were granted to directors vesting in eight equal amounts at the end of every quarter over the next two years. 2,750,000 of the Participant Options were granted to employees, and shall vest in equal installments over the next three years, with one third having vested on June 19th, 2019, a third to vest on June 19, 2020 and the remaining amount on June 19, 2021 The remaining 223,527 of the Participant Options, were awarded to a consultant and vested on June 19th, 2019. All Participant Options shall have an exercise price of CAD$0.25.

A comprehensive discussion of Water Ways’ financial position and results of operations is provided in the Company’s Management Discussion & Analysis (“MD&A”) for the three months ended June 30, 2019 filed on SEDAR and can be found at www.sedar.com.

About Water Ways Technologies
Water Ways is the parent company of Irri-Al-Tal Ltd. (“IAT”) which is an Israeli based agriculture technology company that specializes in providing water irrigation solutions to agricultural producers. IAT competes in the global irrigation water systems market with a focus on developing solutions with commercial applications in the micro and precision irrigation segments of the overall market. At present, IAT’s main revenue streams are derived from the following business units: (i) Projects Business Unit; and (ii) Component and Equipment Sales Unit. IAT was founded in 2003 by Mr. Ohad Haber with a view of capitalizing on the opportunities presented by micro and smart irrigation, while also making a positive mark on society by making these technologies more widely available, especially in developing markets such as Africa and Latin America. IAT’s past projects include vineyards, water reservoirs, fish farms, fresh produce cooling rooms and more, in over 15 countries.

For more information, please contact
Ronnie Jaegermann
Director
+972-54-4202054
ronnie@irri-altal.com
https://www.water-ways-technologies.com/

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to Water Ways. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Water Ways’ current views and intentions with respect to future events, and current information available to Water Ways, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Water Ways in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Water Ways does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Water Ways undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. Water Ways’ results and forward-looking information and calculations may be affected by fluctuations in exchange rates. All figures are in Canadian dollars unless otherwise indicated.

Click here to connect with Water Ways Technologies (TSXV:WWT) for an Investor Presentation.

Source: www.globenewswire.com

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of investors that purchased Aurora Cannabis, Inc. (NYSE: ACB) securities between February 13, 2020 and September 4, 2020 (the “Class Period”). Investors have until December 1, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

Keep reading... Show less

The coming together of two Canadian beverage industry leaders will form a unique vertical in the plant-based mineral and cannabis beverage sectors

Not for Distribution to U.S. Newswire Services or for Dissemination in the United States

Keep reading... Show less

The potential for new disease research and treatments is expanding thanks to the global adoption of marijuana for medical purposes.

As more countries open the doors to the use and investigation of cannabis, medical applications for the drug are set to expand — indeed, the substance has already shown much promise.

However, in terms of treating skin cancer patients, currently the promise of cannabis outpaces any medically confirmed results or applications.

Though there may be individual cases crediting the drug, cannabis and its derivatives are not being applied to treat skin cancer — at least not yet. Read on to learn about the current situation and future possibilities.

Skin cancer, cannabis and medical research

According to the American Cancer Society, skin cancer is the most common type of cancer, accounting for over 5 million cases per year. This category holds many different variations, but the main three types are basal cell carcinomas, squamous cell carcinomas and melanomas; the rest are considered rare.

Melanomas develop in specific areas like the neck and face and can be more serious than their counterparts. Basal and squamous cancer cells, on the other hand, develop based on a person’s sun exposure and mostly appear on the head and neck.

The Canadian Cancer Society states that treatments for non-melanoma skin cancer include surgery, radiation therapy, photodynamic therapy and drug therapy, including the use of topicals.

In the future, cannabis and cancer could be paired up as more research across the globe begins to take place and companies look for new medications and formulations, boosted by the early successes of the drug.

Changes are happening slowly, with one serious improvement being when GW Pharmaceuticals (NASDAQ:GWPH) obtained approval in the US for its cannabidiol (CBD) solution, which treats seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in toddlers.

After going through its clinical trials, the company’s Epidiolex drug received approval from the US Food and Drug Administration, signaling that top medical agencies are ready to confirm the medical prowess of cannabis and its derivatives for the benefit of patients.

Cannabis entering the skincare space

Looking more specifically at cannabis and skin ailments, the National Eczema Association has vouched for CBD as an option in the treatment of eczema, a skin disease that affects over 30 million people in the US.

“It has long been observed that cannabinoids possess anti-inflammatory, antimicrobial and anti-itch qualities,” the Independent reported.

A study from the the University of Colorado School of Medicine is looking further into the use of CBD for patients with psoriasis or eczema who have tried using topical steroids or topical immunomodulators.

Robert Dellavalle, professor of dermatology with the University of Colorado, told Inside Science that CBD products are growing in popularity, but the results are not being collected as properly as they could be.

“I believe it’s a wide-open horizon with tremendous potential that needs to be investigated, but there are a number of regulatory hurdles that need to be overcome and that’s where we are,” he said.

A medical study from the University of Colorado’s Anschutz Medical Campus shows the anti-inflammatory sensibilities of cannabinoids are the main reason why cannabis may be potent in combating skin diseases.

As part of its guide for healthcare practitioners, Tilray (NASDAQ:TLRY) indicates that medical cannabis could aid patients with inflammatory skin diseases such as dermatitis, psoriasis and pruritus.

“And while this research is still relatively formative, the results achieved so far clearly indicate its value and the promising potential of cannabis as effective medicine,” Tilray states.

Dave Berg, chief technology officer for software company Strainprint, told the Investing News Network the lack of sophisticated research has impacted the development of novel therapies for patients using cannabis.

“It’s been very difficult for people to study cannabis in a clinical way, but there’s been a ton observational data … There’s no really strong observational data set that allows us to make proper decisions,” Berg said.

In an effort to increase the research options available for cannabis, the Canadian federal government announced in 2018 that it would spend C$10 million over five years in order to assess the impact of cannabis use on the mental health of Canadians.

The government also promised C$10 million to the Canadian Center on Substance Use and Addiction for research purposes.

CBD skincare products getting traction

Amid developments geared at solving specific skin issues, more general CBD skincare products are also gaining popularity among many consumers.

For example, the introduction of cosmetics with cannabis elements, supported by Canadian licensed producers, is another upcoming element for the skin treatment segment of consumers. While not medical, this avenue does offer more options in terms of cannabis uses.

The endorsement from consumers for CBD ointments and other topicals for skincare has been documented with multiple products launched in the fractured US cannabis market.

One downside of the growth in these products is that it has led companies to make more and more claims about how these items can help with skin conditions. One study from the Journal of the American Medical Association warns that CBD products are often mislabeled online.

Takeaway on cannabis and skin cancer

In order for skin cancer patients to see the potential benefits from treatment with medical cannabis, much still has to change in Canada and abroad.

As the medical and recreational sections of the cannabis space continue drifting apart thanks to legalization efforts, the medical space should get more time to properly research and investigate the drug’s applications.

The early position CBD has gained in terms of skin maintenance and treatment could lead to further research on its impact on more serious diseases.

What’s more, GW Pharmaceuticals’ success, along with increased awareness of the medical benefits of cannabis, is moving the needle on research efforts geared at finding out how capable the drug will be in the medical space.

Keep reading... Show less

The growth of the cannabis industry has made it possible for companies to offer many different investment opportunities through the major exchanges in Canada.

Previously known as the Canadian Venture Exchange, the TSX Venture Exchange is the sibling of Canada’s main listings board, the larger Toronto Stock Exchange.

For those interested in investing in cannabis companies, this exchange offers a variety of cannabis-related businesses, from growers to biotech companies looking for cannabinoid therapies.

Here the Investing News Network offers investors a growing list of all cannabis-related companies listed on the TSXV. Read on to learn more about them and their businesses.

48North (TSXV:NRTH)

This company is a marijuana producer looking to offer a variety of products for the recreational market in Canada, including for the health and wellness industry. 48North is a licensed outdoor grower of cannabis.

Auxly Cannabis Group (TSXV:XLY,OTCQX:CBWTF)

Created by Chuck Rifici, co-founder of Tweed, Auxly Cannabis Group operates as a cannabis streaming investment firm looking to boost various plays related to the sector.

Avricore Health (TSXV:AVCR)

While Avricore Health operates as a healthcare technology company, in 2017 the firm made a deal with Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) for the right to develop and sell endocannabinoid products in Canada to licensed pharmacies.

CanadaBis Capital (TSXV:CANB)

This cannabis company is targeting the Canadian market through a business model that is focused on cultivation, research, product development, retail and hemp.

Emerald Health Therapeutics

This Canadian cannabis company holds a variety of growing assets in the country. The firm holds a 50/50 joint venture for the management of a grower in BC with Village Farms International (TSX:VFF,NASDAQ:VFF).

EnWave (TSXV:ENW,OTC Pink:NWVCF)

EnWave is a technology company that has centered itself in the cannabis business thanks to its Radiant Energy Vacuum drying technology for organic materials. It effectively decreases the time from the harvest to the sale of cannabis products.

Elixxer (TSXV:ELXR,OTCQB:ELIXF)

Through its partners, investment firm Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.

Eve & Co. (TSXV:EVE,OTCQX:EEVVF)

Eve & Co. is a Canadian cannabis producer that, thanks to its subsidiary Natural MedCo, is targeting female consumers, specifically with premier brands.

Experion Holdings (TSXV:EXP,OTCQB:EXPFF)

Formerly known as Viridium Pacific Group, this cannabis investment firm holds a portfolio of assets, including its licensed producer Experion Biotechnologies in BC.

The Flowr Corporation (TSXV:FLWR,OTC Pink:FLWPF)

The Flowr Corporation is a vertically integrated cannabis company working on the cultivation and sale of medical and recreational marijuana in Canada.

FluroTech (TSXV:TEST,OTCQB:FLURF)

FluroTech is a technology company working on a cost-effective testing platform for the cannabis industry at large. The company’s proprietary CompleTest employs fluorescence spectroscopy technology to measure the specific contents of the product.

GTEC Holdings (TSXV:GETC,OTCQB:GGTTF)

This Kelowna-based cannabis company is vertically integrated, with operations in the cultivation, extraction and analytical testing sectors. The company is also pursuing retail operations through various investments.

Harvest One Cannabis (TSXV:HVT,OTCQX:HRVOF)

Harvest One Cannabis is a cannabis company with production and assets spread across Canada, Europe, Israel and Australia. The company gains its reach thanks to its three subsidiaries: United Greeneries, Satipharm and Dream Products.

Hill Street Beverage Company (TSXV:BEER)

This beverage maker has made its name thanks to its development of non-alcoholic beverages. Now the firm will offer consumers cannabis-infused drinks.

INDIVA (TSXV:NDVA,OTCQX:NDVAF)

INDIVA is a company focused on the supply of medical cannabis. Through an acquisition, it holds a licensed producer with an indoor cannabis facility in Ontario.

Khiron Life Sciences (TSXV:KHRN,OTCQB:KHRNF)

Khiron Life Sciences is a Colombia-based cannabis company raising capital in Canada. The firm has declared that it will seek to expand its presence through Latin America, including Mexico.

Meta Growth (TSXV:META)

This company is a retail operator managing cannabis shops across Canada. Meta Growth manages two recreational store brands: Meta Cannabis Supply and NewLeaf Cannabis.

Namaste Technologies (TSXV:N,OTCQB:NXTTF)

After a tumultuous management change, Namaste Technologies has centered back on its investments and the development of its marijuana play, which includes its online platform of cannabis consumer information.

Naturally Splendid Enterprises (TSXV:NSP,OTCQB:NSPDF)

Naturally Splendid Enterprises is a biotech company developing hemp products for consumers in the health and wellness space. It plans to pursue a stake in the edible cannabidiol market as well.

Pharmacielo (TSXV:PCLO,OTCQX:PCLOF)

Pharmacielo is another cannabis company originally from Colombia raising capital in the Canadian markets. The company is headquartered in Canada, but operates part of its marijuana growing in Colombia.

Radient Technologies (TSXV:RTI,OTCQX:RDDTF)

Radient Technologies is an extraction technology company that has dabbled in the cannabis sector thanks to a partnership with licensed producer Aurora Cannabis (TSX:ACB,NYSE:ACB).

Relevium Technologies (TSXV:RLV,OTC Pink:RLLVF)

Thanks to its subsidiary Biocannabix, this company has a cannabis play in the development of pharmaceutical-grade products infused with cannabinoid formulations.

SugarBud Craft Growers (TSXV:SUGR)

Like some other Canadian cannabis producers, this Alberta company specializes in growing and developing craft-style premium cannabis products.

Target Capital (TSXV:TCI)

Doing business as CBi2 Capital, this Alberta-based company’s investment strategy focuses on developing and managing a diversified portfolio of predominantly early stage cannabis opportunities.

Tetra Bio-Pharma (TSXV:TBP,OTCQB:TBPMF)

Tetra Bio-Pharma is researching and developing medicines based on cannabis and its elements.

Therma Bright (TSXV:THRM)

Therma Bright is a medical device company that has a subsidiary seeking to carve up a space in the technology space for medical and recreational marijuana thanks to its pain relief device.

WeedMD (TSXV:WMD,OTCQX:WDDMF)

WeedMD is another Canadian cannabis producer making product for the medical and recreational markets in Canada. Its subsidiaries include WeedMD Rx and CX Industries.

YSS (TSXV:YSS,OTC Pink:YSSCF)

YSS operates as an adult-use cannabis retailer with 17 stores in Canada.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Tactile Systems Technology (NASDAQ:TCMD)
Class Period:
May 7, 2018 – June 8, 2020
Deadline: November 30, 2020
For more info: www.bgandg.com/tcmd

Keep reading... Show less